Sign in
4

Changes in Ownership

ADARx Pharmaceuticals, Inc. Filed Acc 0001729510-26-000006

Options or other derivatives

  • President and CEO acquired 1,024,152 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Li Zhen · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-24 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +1,024,152 1,024,152 D
Loading xslF345X06/form4-09282026_040901.xml…